Accolade Future Growth
Future criteria checks 1/6
Accolade is forecast to grow earnings and revenue by 26.4% and 15% per annum respectively. EPS is expected to grow by 26% per annum. Return on equity is forecast to be -14% in 3 years.
Key information
26.4%
Earnings growth rate
26.0%
EPS growth rate
Healthcare earnings growth | 23.4% |
Revenue growth rate | 15.0% |
Future return on equity | -14.0% |
Analyst coverage | Good |
Last updated | 26 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
2/28/2027 | 687 | -62 | 50 | 58 | 4 |
2/28/2026 | 576 | -83 | 37 | 49 | 12 |
2/28/2025 | 491 | -94 | 24 | 34 | 16 |
2/29/2024 | 414 | -100 | -29 | -16 | N/A |
11/30/2023 | 388 | -123 | -37 | -25 | N/A |
8/31/2023 | 380 | -142 | -46 | -35 | N/A |
5/31/2023 | 371 | -155 | -39 | -30 | N/A |
2/28/2023 | 363 | -460 | -48 | -41 | N/A |
11/30/2022 | 358 | -464 | -46 | -40 | N/A |
8/31/2022 | 350 | -401 | -62 | -57 | N/A |
5/31/2022 | 336 | -417 | -69 | -65 | N/A |
2/28/2022 | 310 | -123 | -66 | -62 | N/A |
11/30/2021 | 275 | -93 | -53 | -50 | N/A |
8/31/2021 | 230 | -132 | -43 | -41 | N/A |
5/31/2021 | 194 | -85 | -47 | -45 | N/A |
2/28/2021 | 170 | -51 | -28 | -25 | N/A |
11/30/2020 | 156 | -48 | -49 | -46 | N/A |
8/31/2020 | 147 | -50 | -41 | -37 | N/A |
5/31/2020 | 140 | -49 | -29 | -26 | N/A |
2/29/2020 | 133 | -51 | -38 | -34 | N/A |
11/30/2019 | 123 | -56 | -25 | -23 | N/A |
2/28/2019 | 95 | -56 | -20 | -17 | N/A |
2/28/2018 | 77 | -61 | -45 | -38 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4NE1 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 4NE1 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 4NE1 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 4NE1's revenue (15% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: 4NE1's revenue (15% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4NE1 is forecast to be unprofitable in 3 years.